Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Hyperkinetic disorders |
French
|
Troubles hyperkinétiques |
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Mental and behavioural disorders | |
| 2 | F90-F98 | Behavioural and emotional disorders with onset usually occurring in childhood and adolescence | |
| 3 | F90 | Hyperkinetic disorders |
| Code | Title | |
|---|---|---|
| F90.0 | Disturbance of activity and attention | |
| F90.1 | Hyperkinetic conduct disorder | |
| F90.8 | Other hyperkinetic disorders | |
| F90.9 | Hyperkinetic disorder, unspecified |
| Active Ingredient | Description | |
|---|---|---|
| Atomoxetine |
Atomoxetine is a highly selective and potent inhibitor of the pre-synaptic noradrenaline transporter, its presumed mechanism of action, without directly affecting the serotonin or dopamine transporters. |
|
| Guanfacine |
Guanfacine is a selective alpha2A-adrenergic receptor agonist in that it has 15-20 times higher affinity for this receptor subtype than for the alpha2B or alpha2C subtypes. Guanfacine is a non-stimulant. The mode of action of guanfacine in ADHD is not fully established. |
|
| Methylphenidate |
Methylphenidate HCl is a mild central nervous system (CNS) stimulant. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Methylphenidate is thought to block the reuptake of noradrenaline and dopamine into the presynaptic neurone and increase the release of these monoamines into the extraneuronal space. |
|
| Tiapride |
Tiapride is an atypical neuroleptic which exhibits selectivity in in-vitro studies for D2 and D3 dopamine subtype receptors without any affinity for subtype receptors of the principal central neurotransmitters (including serotonin, noradrenaline and histamine). |
